TGF-β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease-Reference-Cited by-同舟云学术

TGF-β1 Pathway as a New Target for Neuroprotection in Alzheimer's Disease

Published:2009-11-19 Issue:4 Volume:17 Page:237-249
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:

Author:

Caraci Filippo,Battaglia Giuseppe,Bruno Valeria,Bosco Paolo,Carbonaro Viviana,Giuffrida Maria Laura,Drago Filippo,Sortino Maria Angela,Nicoletti Ferdinando,Copani Agata

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-5949.2009.00115.x/fullpdf

Reference134 articles.

1. Neuropsychiatric symptoms in dementia: Importance and treatment considerations;Ballard;Int Rev Psychiatry,2008

2. Alzheimer's disease: Progress or profit?;Mount;Nature Med,2006

3. Therapeutic approaches to Alzheimer's disease;Klafki;Brain,2006

4. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics;Hardy;Science,2002

5. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers;Demuro;J Biol Chem,2005

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems;AAPS PharmSciTech;2024-09-05

3. Growth Factors and Their Application in the Therapy of Hereditary Neurodegenerative Diseases;Biomedicines;2024-08-20

4. Uncovering the Therapeutic Potential of Lithium Chloride in Type 2 Diabetic Cardiomyopathy: Targeting Tau Hyperphosphorylation and TGF-β Signaling via GSK-3β Inhibition;Pharmaceutics;2024-07-19

5. GeneCOCOA: Detecting context-specific functions of individual genes using co-expression data;2024-06-30